Improving treatment engagement for opioid addiction
EXEMPLAR HOSPITAL INITIATION TRIAL TO ENHANCE TREATMENT ENGAGEMENT (CTN-0098). JUNE 10, 2024 TO NOVEMBER 1, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00003 (TO19).
This study is all about finding better ways to help people with opioid addiction stick to their treatment, working with hospitals to make it easier for patients to get the support they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11220974 on NIH RePORTER |
What this research studies
This research focuses on enhancing treatment engagement for individuals struggling with opioid addiction. It is part of the NIH's HEAL initiative, which aims to develop effective solutions to the opioid crisis. The project will involve collaboration with hospitals to implement strategies that encourage patients to participate in treatment programs. By utilizing evidence-based approaches, the research seeks to identify barriers to treatment and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are currently struggling with opioid addiction or dependence.
Not a fit: Patients who are not experiencing opioid addiction or those who are already in effective treatment programs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies that help individuals overcome opioid addiction.
How similar studies have performed: Previous research under the HEAL initiative has shown promise in developing effective interventions for opioid addiction, indicating that this approach has potential for success.
Where this research is happening
Rockville, United States
- The Emmes Company, LLC — Rockville, United States (Active)
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.